Abstract
We sincerely appreciate the thoughtful comments and constructive feedback by Dr. Zhuo1 regarding our article on the association between proton pump inhibitor (PPI) use and the incidence of intestinal Behçet disease (BD).2 We are grateful for the opportunity to clarify several points and to discuss the limitations and future directions of our research.
